Further studies in cells and zebrafish overexpressing mutant IFITM5 support our observation that activation of this pathway is involved in the mineralization defect and abnormal cartilage development in OI type V (Figure 6 and Supplemental Figure 7). The gene discussed is IFITM5; the disease is osteogenesis imperfecta type 5.